fexofenadine
Selected indexed studies
- Fexofenadine. (Drugs, 1998) [PMID:9506246]
- Why fexofenadine is considered as a truly non-sedating antihistamine with no brain penetration: a systematic review. (Curr Med Res Opin, 2024) [PMID:39028636]
- Clinical pharmacokinetics and pharmacodynamics of desloratadine, fexofenadine and levocetirizine : a comparative review. (Clin Pharmacokinet, 2008) [PMID:18336052]
_Worker-drafted node — pending editorial review._
Connections
fexofenadine is a side effect of
Sources
- Clinical pharmacokinetics and pharmacodynamics of desloratadine, fexofenadine and levocetirizine : a comparative review. (2008) pubmed
- Fexofenadine. (1998) pubmed
- Why fexofenadine is considered as a truly non-sedating antihistamine with no brain penetration: a systematic review. (2024) pubmed
- Fexofenadine hydrochloride--a new anti-histaminic drug. (2001) pubmed
- An update on the clinical pharmacokinetics of fexofenadine enantiomers. (2018) pubmed
- Fexofenadine in pediatrics: oral tablet and suspension formulations. (2008) pubmed
- Fexofenadine: biochemical, pharmacokinetic and pharmacodynamic properties and its unique role in allergic disorders. (2009) pubmed
- Antihistamine effects and safety of fexofenadine: a systematic review and Meta-analysis of randomized controlled trials. (2019) pubmed
- Clinical pharmacokinetics of fexofenadine enantiomers. (2010) pubmed
- Cardiovascular safety of fexofenadine HCl. (1999) pubmed